Pasithea Therapeutics Corp. Warrant
KTTAW
$0.00+0.00%
End of day · as of Sep 24, 2026, 6:17 AM ET
Mkt cap
N/A
EV/Sales
N/A
P/E ratio
N/A
FY2022 Revenue
$486,559
EPS (FY2022)
$-0.55
Gross Margin (FY2022)
76.74%
Profit Margin (FY2022)
-2864.29%
Beta
0.34
Div yield
N/A
Sector
Healthcare
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.
Latest reported KTTAW revenue for 2022-12-31 was $486.6K. Net income was -$13.9M. Revenue was up 3130.4% from 2021-12-31 to 2022-12-31.
Use this KTTAW research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full KTTAW income, balance, and cash tables.
Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company in the Healthcare sector.
Latest cached Pasithea Therapeutics Corp. Warrant (KTTAW) revenue for Dec 31, 2022 was $486.6K. Net income was -$13.9M. Statements: https://lician.com/financials/kttaw
Pasithea Therapeutics Corp. Warrant (KTTAW) cached previous close $0.00; day range $0.00 – $0.00; volume 383. Session quote: https://lician.com/quote/kttaw
The latest cached KTTAW filing is 8-K · Sep 16, 2026. Filings: https://lician.com/sec/kttaw